Heart-First approach may boost survival in lung cancer patients

NCT ID NCT04980716

Recruiting now Disease control Sponsor: Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated Apr 24, 2026 · Updated 19 times

Summary

This study tests whether early, specialized heart monitoring and care can help people with advanced lung cancer live longer and have fewer heart-related side effects while receiving standard cancer treatments like radiation, chemotherapy, and immunotherapy. About 524 adults with stage III non-small cell lung cancer will be randomly assigned to either usual care or early heart-focused intervention. The goal is to see if this approach improves overall survival and reduces serious heart complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sun yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510060, China

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

CARDIOVASCULAR COMPLICATION NON SMALL CELL LUNG CANCER